The development of natural biomaterials is not regarded as a new area of science, but has existed for centuries. The use of natural products as a biomaterial is currently undergoing a renaissance in the biomedical field. The major limitations of natural biomaterials are due to the immunogenic response that can occur following implantation and the lot-to-lot variability in molecular structure associated with animal sourcing. The chemical stability and biocompatibility of natural products in the body greatly accounts for their utilization in recent times. The paper succinctly defines biomaterials in terms of natural products and also that natural products as materials in biomedical fields are considerably versatile and promising. The various types of natural products and forms of biomaterials are highlighted. Three main areas of applications of natural products as materials in medicine are described, namely, wound management products, drug delivery systems, and tissue engineering. This paper presents a brief history of natural products as biomaterials, various types of natural biomaterials, properties, demand and economic importance, and the area of application of natural biomaterials in recent times. 1. Introduction A biomaterial is regarded as any nondrug material that can be used to treat, enhance or replace any tissue, organ, or function in an organism [1]. While the definition of biomaterial was reframed as a nondrug substance suitable for inclusion in systems which augment or replace the function of bodily tissues or organs [2]. This definition explicitly described biomaterial in relation to drugs and as such, there is a need to clarify the impression that natural products are synonymous with drugs. The definition implies that natural products can be applied as biomaterials by eliminating the ambiguity always associated with natural products as drugs. It must be emphasized that this definition is not regarded as one of the most popular and is not often cited as this one which defines biomaterial as a nonviable material that intends to interact with physiological environment [3]. However, in this study, the following definition will be adopted: biomaterial can be defined as any substance (other than a drug) or combination of substances synthetic or natural in origin, which can be used any time, as a whole or as a part of a system which treats, augments, or replaces any tissue, organ or function of the body [4]. It must be noted that in this study the substances are natural in origin. 1.1. Economy The field of biomaterials working under biological
References
[1]
J. P. A. Nicolai and G. Rakhorst, Introduction: Biomaterials in Modern Medicine, 2008, http://www.worldscibooks.com/etextbooks/6562/6562.chap01.pdf.
[2]
G. Heness and B. Ben-Nissan, “Innovative bioceramics,” Materials Forum, vol. 27, pp. 104–114, 2004.
[3]
D. F. Williams, Definition in Biomaterials, Elservier, Amsterdam, The Netherlands, 1987.
[4]
A. F. Von Recum and M. LaBerge, “Educational goals for biomaterials science and engineering: prospective view,” Journal of Applied Biomaterials, vol. 6, no. 2, pp. 137–144, 1995.
[5]
L. Sedel, “Biomaterials: Medical Viewpoint,” 2004, http://www.atsmp.whut.edu.cn/resources/pdf/4078.pdf.
[6]
J. P. Brown, M. Bide, and M. Phaneuf, “Cellular encapsulation into porous alginate fibers,” Tech. Rep. M04-CL13, National Textile Center Research Briefs—Materials Competency, 2005.
[7]
L. M. Zimmerman and I Veith, Great Ideas in the History of Surgery, Norman Publishers, New York, NY, USA, 1st edition, 1993.
[8]
DSM, Corporate Communications, A Brief History of Biomedical Materials, 2009, http://www.dsm.com/en_US/cworld/public/medical downloads/.
[9]
R. H. Doremus, “Review—bioceramics,” Journal of Materials Science, vol. 27, no. 2, pp. 285–297, 1992.
[10]
J. C. Coburn and A. Pandit, “Chapter 13: development of naturally-derived biomaterials and optimization of their biomechanical properties,” in Topics in Tissue Engineering, supplement 13, pp. 1–23, 2007.
[11]
Y. Cao and B. Wang, “Biodegradation of silk biomaterials,” International Journal of Molecular Sciences, vol. 10, no. 4, pp. 1514–1524, 2009.
[12]
K. McLean, “Evaluation of Biomaterial Performance,” 2006, http://www.csiro.au/.
[13]
N. Ivanova, “Biomaterials: Silk as a Natural Biomaterial,” 2005, http://www.sinc.sunysb.edu.edu/.
[14]
B. D. Ratner, A. S. Hoffmann, F. J. Schoen, and J. C. Lemons, Biomaterials Science: An Introduction to Materials in Medicine, Elsevier Academic Press, London, UK, 2nd edition, 2004.
[15]
P. Heffernan, “Section 3: discovery research measure (2007–2013), marine biodiscovery/biotechnology research programme,” in Sea Change—A Marine Knowledge, Research and Innovation Strategy for Ireland (2007–2013), Marine Institute, Rinville Oranmore, Galway, Ireland, 2006.
[16]
ASMI, “Overview of biomaterials and their use in medical devices,” in Handbook of Materials for Medical Devices, 2003, http://asmiinternational.org/bookstore.
[17]
P. Fratzl, “Biomimetic materials research: what can we really learn from nature's structural materials?” Journal of the Royal Society Interface, vol. 4, no. 15, pp. 637–642, 2007.
[18]
R. Schoental, “Toxicology of natural products,” Food and Cosmetics Toxicology, vol. 3, no. 4, pp. 609–620, 1965.
[19]
G. A. Holt and A. Chandra, “Herbs in the modern healthcare environment—an overview of uses, legalities, and the role of the healthcare professional,” Clinical Research and Regulatory Affairs, vol. 19, no. 1, pp. 83–107, 2002.
[20]
C. B. Spainhour, “Natural products,” in Drug Discovery Handbook, pp. 11–72, John Wiley & Sons, Inc., New York, NY, USA, 2005.
[21]
B. B. Jarvis, “Evolution of metabolic pathways,” in The Role of Natural Products in Evolution, J. T. Romeo, Ed., vol. 34, pp. 1–24, 1st edition, 2000.
K. Nakanishi, “An historical perspective of natural products chemistry,” in Comprehensive Natural Products Chemistry, vol. 8, pp. 21–48, 1999.
[25]
B. R. O'Keefe, “Biologically active proteins from natural product extracts,” Journal of Natural Products, vol. 64, no. 10, pp. 1373–1381, 2001.
[26]
J. D. Connolly, “Natural products from around the world,” Revista Latinoamericana de Quimica, vol. 25, no. 2, pp. 77–85, 1997.
[27]
K. H. Lee, “Anticancer drug design based on plant-derived natural products,” Journal of Biomedical Science, vol. 6, no. 4, pp. 236–250, 1999.
[28]
G. W. Qin and R. S. Xu, “Recent advances on bioactive natural products from Chinese medicinal plants,” Medicinal Research Reviews, vol. 18, no. 6, pp. 375–382, 1998.
[29]
V. J. Ram and S. Kumari, “Natural products of plant origin as anticancer agents,” Drug News and Perspectives, vol. 14, no. 8, pp. 465–482, 2001.
[30]
C. Acharya, B. Hinz, and S. C. Kundu, “The effect of lactose-conjugated silk biomaterials on the development of fibrogenic fibroblasts,” Biomaterials, vol. 29, no. 35, pp. 4665–4675, 2008.
[31]
C. Acharya, S. K. Ghosh, and S. C. Kundu, “Silk fibroin protein from mulberry and non-mulberry silkworms: cytotoxicity, biocompatibility and kinetics of L929 murine fibroblast adhesion,” Journal of Materials Science, vol. 19, no. 8, pp. 2827–2836, 2008.
[32]
N. Minoura, M. Tsukada, and M. Nagura, “Physico-chemical properties of silk fibroin membrane as a biomaterial,” Biomaterials, vol. 11, no. 6, pp. 430–434, 1990.
[33]
N. Minoura, S. I. Aiba, M. Higuchi, Y. Gotoh, M. Tsukada, and Y. Imai, “Attachment and growth of fibroblast cells on silk fibroin,” Biochemical and Biophysical Research Communications, vol. 208, no. 2, pp. 511–516, 1995.
[34]
M. Santin, A. Motta, G. Freddi, and M. Cannas, “In vitro evaluation of the inflammatory potential of the silk fibroin,” Journal of Biomedical Materials Research, vol. 46, no. 3, pp. 382–389, 1999.
[35]
L. Meinel, R. Fajardo, S. Hofmann et al., “Silk implants for the healing of critical size bone defects,” Bone, vol. 37, no. 5, pp. 688–698, 2005.
[36]
G. M. Cragg and D. J. Newman, “Natural product drug discovery in the next millenium,” Pharmaceutical Biology, vol. 39, supplement 1, pp. 8–17, 2001.
[37]
A. M. Burja, B. Banaigs, E. Abou-Mansour, J. Grant Burgess, and P. C. Wright, “Marine cyanobacteria — a profile source of natural products,” Tetrahedron, vol. 57, no. 46, pp. 9347–9377, 2001.
[38]
D. J. Faulkner, “Marine natural products,” Natural Product Reports, vol. 17, no. 1, pp. 7–55, 2000.
[39]
D. J. Faulkner, “Highlights of marine natural products chemistry (1972–1999),” Natural Product Reports, vol. 17, no. 1, pp. 1–6, 2000.
[40]
D. J. Faulkner, “Marine natural products,” Natural Product Reports, vol. 19, no. 1, pp. 1–48, 2002.
[41]
G. M. K？nig and A. D. Wright, “Marine natural products research: current directions and future potential,” Planta Medica, vol. 62, no. 3, pp. 193–211, 1996.
[42]
K. Liberra and U. Lindequist, “Marine fungi—a prolific resource of biologically active natural products?” Pharmazie, vol. 50, no. 9, pp. 583–588, 1995.
[43]
J. K. Volkman, “Australasian research on marine natural products: chemistry, bioactivity and ecology,” Marine and Freshwater Research, vol. 50, no. 8, pp. 761–779, 1999.
[44]
B. Haefner, “Drugs from the deep: marine natural products as drug candidates,” Drug Discovery Today, vol. 8, no. 12, pp. 536–544, 2003.
[45]
N. Fusetani, “Introduction,” in Drugs from the Sea, N. Fusetani, Ed., Karger, Basel, Switzerland, 2000.
[46]
A. Kelecom, “Chemistry of marine natural products: yesterday, today and tomorrow,” Anais da Academia Brasileira de Ciencias, vol. 71, no. 2, pp. 249–263, 1999.
[47]
L. L. Hench, “Bioceramics: from concept to clinic,” Journal of the American Ceramic Society, vol. 74, no. 7, pp. 1487–1510, 1991.
[48]
L. L. Hench and S. Best, “Ceramics, glasses and glass-ceramics,” in Biomaterials Science: An Introduction to Materials in Medicine, B. D. Ratner, A. S. Hoffmann, F. J. Schoen, and J. E. Lemons, Eds., Elsevier Academic Press, London, UK, 2004.
[49]
S. H. Gupta SH, “Mineralized tissues,” Tech. Rep., Department of Biomaterials, Biomaterials, Max Planck Institute of Colloids and Interfaces, Postdam, Germany, 2005-2006.
[50]
P. Fratzl, “Bone material quality and Osteoporosis research,” in Research in the Department of Biomaterials, Biomaterials, Max Planck Institute of Colloids and Interfaces, Biannual Report (2005-2006), P. Fratzl, Ed., Postdam, Germany, 2006.
[51]
P. Fratzl, The Bone Quality Book—A Guide to Factors Influencing Bone Strength, Materials Properties: Mineral Crystals, Excerota Medica, Amsterdam, The Netherlands, 2006, Edited by Dempster D., Felsenberg D. and Van Der Geest S.
[52]
F. C. M. Driessens, “Formation and stability of calcium phosphate in relatuion to the phase composition of the mineral in calcified tissue,” in Bioceramics of Calcium Phosphate, K. DeGroot, Ed., CRC Press, Boca Raton, Fla, USA, 1983.
[53]
C. Balázsi, F. Wéber, Z. K？vér , E. Horváth, and C. Németh, “Preparation of calcium-phosphate bioceramics from natural resources,” Journal of the European Ceramic Society, vol. 27, no. 2-3, pp. 1601–1606, 2007.
[54]
P. Chattopadhyay, S. Pal, A. K. Wahi, L. Singh, and A. Verma, “Synthesis of crystalline hydroxyapetite from coral (Gergonacea sp) and cytotoxicity evaluation,” Trends in Biomaterials and Artificial Organs, vol. 20, no. 2, pp. 139–142, 2007.
[55]
G. Guillenium, J. Patat, J. Fournie, and M. Chetail, “The use of coral as a bone graft substitute,” Journal of Biomedical Materials Research, vol. 21, no. 5, pp. 557–567, 1987.
[56]
M. Richard, E. Aguado, G. Daculsi, and M. Cottrel, “Ultrastructural and electron diffraction of the bone-ceramic interfacial zone in coral and biphasic calcium phosphate implants.,” Calcified Tissue International, vol. 62, no. 5, pp. 437–442, 1998.
[57]
C. Demers, C. R. Hamdy, K. Corsi, F. Chellat, M. Tabrizian, and L. Yahia, “Natural coral exoskeleton as a bone graft substitute: a review,” Bio-Medical Materials and Engineering, vol. 12, no. 1, pp. 15–35, 2002.
[58]
J. Chou, B. Ben-Nissan, A. H. Choi, R. Wuhrer, and D. Green, “Conversion of coral sand to calcium phosphate for biomedical applications,” Journal of the Australian Ceramic Society, vol. 43, no. 1, pp. 44–48, 2007.
[59]
J. Hu, J. J. Russell, R. Vago, and B. Ben-Nissan, “Production and analysis of hydroxyapatite from Australian corals via hydrothermal process,” Journal of Materials Science Letters, vol. 20, no. 1, pp. 85–87, 2001.
[60]
R. Z. LeGeros, “Properties of osteoconductive biomaterials: calcium phosphates,” Clinical Orthopaedics and Related Research, no. 395, pp. 81–98, 2002.
[61]
Y. Barbotteau, J. L. Irigaray, and J. F. Mathiot, “Modelling by percolation theory of the behaviour of natural coral used as bone substitute,” Physics in Medicine and Biology, vol. 48, no. 21, pp. 3611–3623, 2003.
[62]
F. Roux, D. Brasnu, B. Loty, B. Georges, and G. Guillenimin, “Madreporic coral: a new bone graft substitute for cranial surgery,” Journal of Biomedical Materials Research, vol. 69, no. 4, pp. 510–513, 1988.
[63]
E. Arnaud, C. Morieux, M. Wybier, and M. C. De Vernejoul, “Potentiation of transforming growth factor (TGF-β1) by natural coral and fibrin in a rabbit cranioplasty model,” Calcified Tissue International, vol. 54, no. 6, pp. 493–498, 1994.
[64]
R. A. Yukna, “Clinical evaluation of coralline calcium carbonate as a bone replacement graft material in human periodontal osseous defects,” Journal of Periodontology, vol. 65, no. 2, pp. 177–185, 1994.
[65]
A. J. Awang-Hazmi, A. B. C. Z. Zuki, M. M. Noordim, A. Jalila, and Y. Norimah, “Mineral composition of the cockle (Anadara Granosa) shells of west coast of peninsular malaysia and it’s potential as biomaterial for use in bone repair,” Journal of Animal and Veterinary Advances, vol. 6, no. 5, pp. 591–594, 2007.
[66]
A. B. Rodríguez-Navarro, C. CabraldeMelo, N. Batista, et al., “Microstructure and crystallographic-texture of giant barnacle (Austromegabalanus psittacus) shell,” Journal of Structural Biology, vol. 156, no. 2, pp. 355–362, 2006.
[67]
R. C. Herdman, “U.S. Congress, office of technology assessment, biopolymers: making materials nature’s way,” Tech. Rep. OTA-BP-E-102, US Government Printing Office, Washington, DC, USA, 1998, 1998, http://www.fas.org/ota/reports/9313.pdf.
[68]
D. R. Lu, C. M. Xiao, and S. J. Xu, “Starch-based completely biodegradable polymer materials,” Express Polymer Letters, vol. 3, no. 6, pp. 366–375, 2009.
[69]
R. E. Baier, “Advanced biomaterials development from natural products,” Journal of Biomaterials Applications, vol. 2, no. 4, pp. 615–626, 1988.
[70]
R. L. Reis, Natural-Based Polymers for Biomedical Applications, Woodhead Publishing Limited, Abinghton, UK, 2008.
[71]
L. G. Griffith, “Biomaterials,” WTEC Panel Report on Tissue Engineering Research, WTEC, 2003.
[72]
T. J. Lujan, “Biomaterials science ME 491: lecture 5: natural polymers,” 2010, http://www.biomechresearch.org/staff/lujan/teaching/Biomtrl_5%20Natural%20Polymers.pdf.
[73]
“Natural Polymers US Industry Study with Forecasts to 2010 and 2015,” 2007, http://www.bharatbook.com.
[74]
S. L. Cooper, S. A. Visser, R. W. Hergenrother, and N. M. K. Lamba, “Polymer,” in Biomaterials Science: An Introduction to Materials in Medicine, B. D. Ratner, A. S. Hoffman, F. J. Schoen, and J. E. Lemons, Eds., pp. 67–79, Elsevier, London, UK, 2nd edition, 2004.
[75]
I. V. Yannas, “Natural Materials,” in Biomaterials Science: An Introduction to Materials in Medicine, B. D. Ratner, A. S. Hoffman, F. J. Schoen, and J. E. Lemons, Eds., Elsevier, London, UK, 2nd edition, 2004.
[76]
P. R. Shewry, A. S. Tatham, and A. J. Bailey, Elastomeric Proteins: Structures, Biomechanical Properties, and Biological Roles, Cambridge University Press, 2003.
[77]
K. Yao, J. Mao, J. Yin, et al., “Chitosan/gelatin network based biomaterials in tissue engineering,” Biomedical Engineering Applications Basis and Communications, vol. 14, no. 3, pp. 115–121, 2002.
[78]
S. B. Lee, H. W. Jeon, Y. W. Lee, et al., “Artificial dermis composed of gelatin, hyaluronic acid and (1–3), (1–6), -β—Glucan,” Macromolecular Research, vol. 11, no. 5, pp. 368–374, 2003.
[79]
J. Wood, “Tissue-like constructs made in minutes,” Materials Today, vol. 8, no. 12, p. 22, 2003.
[80]
H. J. Jin, J. Park, R. Valluzzi, P. Cebe, and D. L. Kaplan, “Biomaterial films of bombyx mori silk fibroin with poly (ethylene oxide),” Biomacromolecules, vol. 5, no. 3, pp. 711–717, 2004.
[81]
S. Prasong, S. Yaowalak, and S. Wilaiwan, “Characteristics of silk fiber with and without sericin component: a comparison between botnbyx tnori and philosamia ricini silks,” Pakistan Journal of Biological Sciences, vol. 12, no. 11, pp. 872–876, 2009.
[82]
A. Mueller, Engineering Biomedical Materials from Corn and Wool, Alcht, Chemical Engineering Progress (CEP), 2005.
[83]
T. Aboushwareb, D. Eberli, C. Ward, et al., “A keratin biomaterial gel hemostat derived from human hair: evaluation in a rabbit model of lethal liver injury,” Journal of Biomedical Materials Research, vol. 90, no. 1, pp. 45–54, 2009.
[84]
P. Sierpinski, J. Garrett, J. Ma, et al., “The use of keratin biomaterials derived from human hair for the promotion of rapid regeneration of peripheral nerves,” Biomaterials, vol. 29, no. 1, pp. 118–128, 2008.
[85]
W. F. P. Neves-Junior, M. Ferreira, M. C. O. Alves, et al., “Influence of fabrication process on the final properties of natural-rubber latex tubes for vascular prosthesis,” Brazilian Journal of Physics, vol. 36, no. 2, pp. 586–591, 2006.
[86]
F. Mrue, J. Coutinho-Netto, R. Ceneviva, J. J. Lachat, J. A. Thomazini, and H. Tambelini, “Evaluation of the biocompatibility of a new biomembrane,” Materials Research, vol. 7, no. 2, pp. 277–283, 2004.
[87]
E. S. Stevens, Green Plastics, an Introduction to the New Acience of Biodegradable Plastics, Princeton University Press, Princeton, NJ, USA, 2002.
[88]
A. Atala and D. J. Mooney, Synthetic Biodegradable Polymer Scaffolds, Birkh？user, Boston, Mass, USA, 1997.
[89]
A. R. Talja, Preparation and characterization of potato starch films plasticized with polyols, Ph.D. thesis, University of Helsinki, Helsinki, Finland, 2007.
[90]
A. K. Sugih, Synthesis and properties of starch based biomaterials, Ph.D. thesis, University of Groningen, Groningen, The Netherlands, 2008.
[91]
C. G. Biliaderis, “Structure and phase transition of starch in food systems,” Food Technology, vol. 46, no. 6, pp. 98–109, 1992.
[92]
J. C. Vengal and M. Srikumar, “Processing and study of novel lignin-starch and lignin-gelatin biodegradable polymeric films,” Trends in Biomaterials and Artificial Organs, vol. 18, no. 2, pp. 237–241, 2005.
[93]
L. S. Nair and C. T. Laurencin, “Polymers as biomaterials for tissue engineering and controlled drug delivery,” Advances in Biochemical Engineering/Biotechnology, vol. 102, pp. 47–90, 2006.
[94]
A. P. Marques, Biofunctionality and immunocompatibility of starch-based biomaterials, Ph.D. thesis, Departmento engenharia polimerios, Universidale Do Minho, Escola de Engenharia, 2004.
[95]
K. Sriroth, R. Onollakup, K. Piyachomkwan, and C. G. Oates, “Biodegradable plastics from cassava starch in Thailand,” 1999, http://www.ciat.cgiar.org/Paginas/index.aspx.
[96]
E. Khor, “Chitin: a biomaterial in waiting,” Current Opinion in Solid State and Materials Science., vol. 6, no. 4, pp. 313–317, 2002.
[97]
E. Khor, “Chitin and chitosan as biomaterials: going forward based on lessons learnt,” Journal of Metals, Materials and Minerals, vol. 15, no. 1, pp. 69–72, 2005.
[98]
J. F. Louvier-Hernandez, R. A. Mauricio-Sanchez, G. A. Camacho-Bragado, G. Luna-Barcenas, and R. B. Gupta, “Chitin nanofibrous three-dimensional scaffold prepared by supercritical antisolvent precipitation,” in Proceedings of the 8th Inter American Congress of Electron Microscopy, La Hanaba, Cuba, September 2005.
[99]
R. Naznin, “Extraction of chitin and chitosan from shrimp (Metapenaeus monoceros) shell by chemical method,” Pakistan Journal of Biological Sciences, vol. 8, no. 7, pp. 1051–1054, 2005.
[100]
P. K. Dutta, J. Duta, and V. S. Tripathi, “Chitin and chitosan: chemistry, properties and applications,” Journal of Scientific and Industrial Research, vol. 63, no. 1, pp. 20–31, 2004.
[101]
M. M. Saad, “Chelating ability of the chitosan-glucan complex from aspergillus niger NRRL595 biomass recycling in citric acid production,” Research Journal of Agric & Biological Sciences, vol. 2, no. 3, pp. 132–136, 2006.
[102]
S. Hirano and T. Midorikawa, “Novel method for the preparation of N-acylchitosan fiber and N-acylchitosan-cellulose fiber,” Biomaterials, vol. 19, no. 1–3, pp. 293–297, 1998.
[103]
A. Blasinka, I. Krucinska, and M. Chrzanowski, “Dibutyrylchitin nonwoven biomaterials manufacturing using electrospinning method,” Fibres and Textiles in Eastern Europe, vol. 4, no. 48, pp. 51–55, 2004.
[104]
R. Shelma, W. Paul, and C. P. Sharma, “Chitin nanofibre reinforced thin chitosan films for wound healing application,” Trends in Biomaterials and Artificial Organs, vol. 22, no. 2, pp. 107–111, 2008.
[105]
M. Beran, M. Urban, L. Adamek, L. Jandusik, and J. Speracek, “Applications of mushroom chitosans in medical biomaterials,” 2007, http://www.vupp.cz/.
[106]
S. Honary, M. Maleki, and M. Karami, “The effect of chitosan molecular weight on the properties of alginate/chitosan microparticles containing prednisolone,” Tropical Journal of Pharmaceutical Research, vol. 8, no. 1, pp. 53–61, 2009.
[107]
“Natural polymers US industry study with forecasts to 2010 and 2015,” 2007, http://www.bharatbook.com.
[108]
Y. M. Tsujisaka and M. Tsuhashi, “Pullulan,” in Industrial Gums: Polysaccharides and Their Derivatives, R. Whistkler and J. N. BeMiller, Eds., pp. 447–460, Academic Press, San Diego, Calif, USA, 1993.
[109]
M. R. Rekha and C. P. Sharma, “Pullulan as a promising biomaterials for biomedical applications: a perspective,” Trends in Biomaterials and Artificial Organs, vol. 20, no. 2, pp. 116–121, 2007.
[110]
US Congress, “Office of technology assessment, biopolymers: making materials nature’s way,” Tech. Rep. OTA-BP-E-102, US Government Printing Office, Washington, DC, USA, 1993.
[111]
U. Hasegawa, S. M. Nomura, S. C. Kaul, T. Hirano, and K. Akiyosh, “Nanogel-quantum dot hybrid nanoparticles for live cell imaging,” Biochemical and Biophysical Research Communications, vol. 331, no. 4, pp. 917–921, 2005.
[112]
H. Hasuda, O. H. Kwon, I. K. Kang, and Y. Ito, “Synthesis of photoreactive pullulan for surface modification,” Biomaterials, vol. 26, no. 15, pp. 2401–2406, 2005.
[113]
Y. Ito and M. Nogawa, “Preparation of a protein micro-array using a photo-reactive polymer for a cell-adhesion assay,” Biomaterials, vol. 24, no. 18, pp. 3021–3026, 2003.
[114]
D. Hull and T. W. Clyne, An Introduction to Composite Materials, Cambridge University Press, Cambridge, Mass, USA, 2nd edition, 1981.
[115]
F. L. Matthews and R. D. Rawlings, Composite Materials Engineering and Science, Chapman & Hall/CRC, London, UK, 1994.
[116]
O. G？ser？d, A. Sannes, and G. Skj？k-Br？k, “Microcapsules of alginate-chitosan. II. a study of capsule stability and permeability,” Biomaterials, vol. 20, no. 8, pp. 773–783, 1999.
[117]
A. Sannino, S. Pappadà, M. Madaghiele, A. Maffezzoli, L. Ambrosio, and L. Nicolais, “Crosslinking of cellulose derivatives and hyaluronic acid with water-soluble carbodiimide,” Polymer, vol. 46, no. 21, pp. 11206–11212, 2005.
[118]
T. Ito, Y. Yeo, C. B. Highley, E. Bellas, C. A. Benitez, and D. S. Kohane, “The prevention of peritoneal adhesions by in situ cross-linking hydrogels of hyaluronic acid and cellulose derivatives,” Biomaterials, vol. 28, no. 6, pp. 975–983, 2007.
[119]
A. Sannino, C. Demitri, and M. Madaghiele, “Biodegradable cellulose-based hydrogels: design and applications,” Materials, vol. 2, no. 2, pp. 353–373, 2009.
[120]
Y. Tokiwa, A. Iwamoto, and M. Koyama, “Development of biodegradable plastics containing polycaprolactose and/or starch,” American Chemical Society, Division of Polymeric Materials, vol. 63, pp. 742–746, 1990.
[121]
Y. Tokiwa, T. Ando, T. Suzuki, and T. Takeda, “Biodegradation of synthetic polymers containing ester bonds,” Proceedings of the ACS Division of Polymeric Materials, vol. 62, pp. 988–992, 1990.
[122]
M. Zhai, L. Zhao, F. Yoshii, and T. Kume, “Study on antibacterial starch/chitosan blend film formed under the action of irradiation,” Carbohydrate Polymers, vol. 57, no. 1, pp. 83–88, 2004.
[123]
D. R. Lu, C. M. Xiao, and S. J. Xu, “Starch-based completely biodegradable polymer materials,” Express Polymer Letters, vol. 3, no. 6, pp. 366–375, 2009.
[124]
S. C. Mendes, R. L. Reis, Y. P. Bovell, A. M. Cunha, C. A. Van Blitterswijk, and J. D. De Bruijn, “Biocompatibility testing of novel starch-based materials with potential application in orthopaedic surgery: a preliminary study,” Biomaterials, vol. 22, no. 14, pp. 2057–2064, 2001.
[125]
A. P. Marques, R. L. Reis, and J. A. Hunt, “The biocompatibility of novel starch-based polymers and composites: in vitro studies,” Biomaterials, vol. 23, no. 6, pp. 1471–1478, 2002.
[126]
H. S. Azevedo, F. M. Gama, and R. L. Reis, “In vitro assessment of the enzymatic degradation of several starch based biomaterials,” Biomacromolecules, vol. 4, no. 6, pp. 1703–1712, 2003.
[127]
L. F. Boesel, J. F. Mano, and R. L. Reis, “Optimization of the formulation and mechanical properties of starch based partially degradable bone cements,” Journal of Materials Science, vol. 15, no. 1, pp. 73–83, 2004.
[128]
A. V. Reis, M. R. Guilherme, T. A. Moia, L. H. C. Mattoso, E. C. Muniz, and E. B. Tambourgi, “Synthesis and characterization of a starch-modified hydrogel as potential carrier for drug delivery system,” Journal of Polymer Science, A, vol. 46, no. 7, pp. 2567–2574, 2008.
[129]
N. A. Peppas, P. Bures, W. Leobandung, and H. Ichikawa, “Hydrogels in pharmaceutical formulations,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 50, no. 1, pp. 27–46, 2000.
[130]
K. J. Zhu, L. Xiangzhou, and Y. Shilin, “Preparation, characterization and properties of polylactide (PLA)-poly(ethylene glycol) (PEG) copolymers. A potential drug carrier,” Journal of Applied Polymer Science, vol. 39, no. 1, pp. 1–9, 1990.
[131]
C. S. Pereira, A. M. Cunha, R. L. Reis, B. Vázquez, and J. San Román, “New starch-based thermoplastic hydrogels for use as bone cements or drug-delivery carriers,” Journal of Materials Science, vol. 9, no. 12, pp. 825–833, 1998.
[132]
C. Bastiol, “Starch-polymer composites,” in Degradable Polymer-Principles and Applications, p. 112, Chapman & Hall, London, UK, 1995.
[133]
R. L. Reis, A. M. Cunha, and M. J. Bevis, “Using non-conventional processing routes to develop anisotropic and buiodegradable composites of starch-based thermoplastic reinforced with bone-like ceramics,” Medical Plastics and Biomaterials Magazine, vol. 4, pp. 46–50, 1997.
[134]
W. Bonfield, M. D. Grynpas, A. E. Tully, J. Bowman, and J. Abram, “Hydroxyapatite reinforced polyethylene—a mechanically compatible implant material for bone replacement,” Biomaterials, vol. 2, no. 3, pp. 185–186, 1981.
[135]
W. Bonfield, “Composite biomaterials, in bioceramics,” in Proceedings of the 9th International Symposium on Ceramics in Medicine, T. Kukubo, T. Nakamura, and F. Miyaji, Eds., Pergamon, Otsu, Japan, 1996.
[136]
C. L. Jardelino, D. R. Gomes, I. I. Castro-Silva, M. H. Rocha-Leao, A. M. Rossi, and J. M. Granjeiro, “Tissue behaviour in response to alginate-hydroxyapatite-capsule containing membrane,” in Proceedings of the 11th International Conference on Advanced Materials (ICAM '09), Rio de Janeiro, Brazil, September0 2009.
[137]
T. W. Bauer and G. F. Muschler, “Bone graft materials: an overview of the basic science,” Clinical Orthopaedics and Related Research, vol. 371, pp. 10–27, 2000.
[138]
W. K. Czaja, D. J. Young, M. Kawecki, and R. M. Brown, “The future prospects of microbial cellulose in biomedical applications,” Biomacromolecules, vol. 8, no. 1, pp. 1–12, 2007.
[139]
Y. Levi-Kalisman, G. Falini, L. Addadi, and S. Weiner, “Structure of the nacreous organic matrix of a bivalve mollusk shell examined in the hydrated state using Cryo-TEM,” Journal of Structural Biology, vol. 135, no. 1, pp. 8–17, 2001.
[140]
A. G. Checa, J. H. E. Cartwright, and M. G. Willinger, “The key role of the surface membrane in why gastropod nacre grows in towers,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 1, pp. 38–43, 2009.
[141]
S. Camprasse, G. Camprasse, M. Pouzol, and E. Lopez, “Artifical dental root made of natural calcium carbonate (bioracine),” Clinical Materials, vol. 5, no. 2–4, pp. 235–250, 1990.
[142]
G. Atlan, N. Balmain, S. Berland, B. Vldal, and E. Lopez, “Reconstruction of human maxillary defects with nacre powder: histological evidence for bone regeneration,” Comptes Rendus de l'Academie des Sciences—Serie III, vol. 320, no. 3, pp. 253–258, 1997.
[143]
M. Joshi, S. W. Ali, and R. Purwar, “Ecofriendly antimicrobial finishing of textiles using bioactive agents based on natural products,” Indian Journal of Fibre and Textile Research, vol. 34, no. 3, pp. 295–304, 2009.
[144]
V. R. Sinha and R. Kumria, “Polysaccharides in colon-specific drug delivery,” International Journal of Pharmaceutics, vol. 224, no. 1-2, pp. 19–38, 2001.
[145]
M. Veerapandian and K. Yun, “The state of the art in biomaterials as nanobiopharmaceuticals,” Digest Journal of Nanomaterials and Biostructures, vol. 4, no. 2, pp. 243–262, 2009.
[146]
F. Iemma, U. G. Spizzirri, F. Puoci, et al., “pH-Sensitive hydrogels based on bovine serum albumin for oral drug delivery,” International Journal of Pharmaceutics, vol. 312, no. 1-2, pp. 151–157, 2006.
[147]
C. Y. Gan, L. H. Cheng, E. T. Phuah, P. N. Chin, A. F. M. AlKarkhi, and A. M. Easa, “Combined cross-linking treatments of bovine serum albumin gel beadlets for controlled-delivery of caffeine,” Food Hydrocolloids, vol. 23, no. 5, pp. 1398–1405, 2009.
[148]
O. A. Diak, A. Bani-Jaber, B. Amro, D. Jones, and G. P. Andrews, “The manufacture and characterization of casein films as novel tablet coatings,” Food and Bioproducts Processing C, vol. 85, no. 3, pp. 284–290, 2007.
[149]
K. Yamauchi, H. Hojo, Y. Yamamoto, and T. Tanabe, “Enhanced cell adhesion on RGDS-carrying keratin film,” Materials Science and Engineering C, vol. 23, no. 4, pp. 467–472, 2003.
